<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://emdrive.echothis.com/index.php?action=history&amp;feed=atom&amp;title=Uses_Side_Consequences_Communications_Photo_Warnings_Application.</id>
	<title>Uses Side Consequences Communications Photo Warnings Application. - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://emdrive.echothis.com/index.php?action=history&amp;feed=atom&amp;title=Uses_Side_Consequences_Communications_Photo_Warnings_Application."/>
	<link rel="alternate" type="text/html" href="http://emdrive.echothis.com/index.php?title=Uses_Side_Consequences_Communications_Photo_Warnings_Application.&amp;action=history"/>
	<updated>2026-09-11T03:00:02Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.41.1</generator>
	<entry>
		<id>http://emdrive.echothis.com/index.php?title=Uses_Side_Consequences_Communications_Photo_Warnings_Application.&amp;diff=458127&amp;oldid=prev</id>
		<title>AmelieKeble0591 at 16:33, 22 August 2024</title>
		<link rel="alternate" type="text/html" href="http://emdrive.echothis.com/index.php?title=Uses_Side_Consequences_Communications_Photo_Warnings_Application.&amp;diff=458127&amp;oldid=prev"/>
		<updated>2024-08-22T16:33:59Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 09:33, 22 August 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Before starting &lt;/del&gt;SABRIL, inform your doctor &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;regarding all &lt;/del&gt;of your (or your &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;child&lt;/del&gt;'s) &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;medical conditions including &lt;/del&gt;clinical depression, mood &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;problems&lt;/del&gt;, self-destructive &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;ideas &lt;/del&gt;[https://www.&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;symbaloo&lt;/del&gt;.com/&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;embed/shared/AAAABVLIzQ8AA41_0kZ5qw== vigabatrin trade name&lt;/del&gt;] or behavior, any type of allergy to SABRIL, vision &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;issues&lt;/del&gt;, kidney &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;issues&lt;/del&gt;, low red cell &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;matters &lt;/del&gt;(anemia), and any kind of nervous or psychological ailment.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The Vigabatrin REMS Program is &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;required &lt;/del&gt;by the FDA to make &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;certain educated &lt;/del&gt;risk-benefit decisions prior to &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;launching &lt;/del&gt;therapy, and to &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;make sure proper &lt;/del&gt;use &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;of &lt;/del&gt;vigabatrin while people are treated. When vision loss will &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;take place&lt;/del&gt;, it is not feasible for your &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;healthcare supplier &lt;/del&gt;to recognize. &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;It is recommended that your healthcare provider examination your (or your kid's) vision prior to or within 4 weeks after beginning &lt;/del&gt;SABRIL &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;and a minimum of every &lt;/del&gt;3 &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;months throughout treatment until SABRIL &lt;/del&gt;is &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;stopped&lt;/del&gt;. &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;If &lt;/del&gt;you &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;or your kid &lt;/del&gt;have any type of &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;side impact that bothers you or that does not go away, inform your healthcare service provider&lt;/del&gt;.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Tell your &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;healthcare provider &lt;/del&gt;if you are expectant or &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;mean &lt;/del&gt;to obtain expectant. If vision screening can not be done, your doctor may continue &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;suggesting &lt;/del&gt;SABRIL, &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;yet &lt;/del&gt;will certainly not be able to &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;look &lt;/del&gt;for any type of vision loss. &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;If vision tests are not done frequently, your doctor &lt;/del&gt;might quit &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;suggesting &lt;/del&gt;SABRIL for you (or your youngster).&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Prior to beginning &lt;/ins&gt;SABRIL, inform your doctor &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;concerning every one &lt;/ins&gt;of your (or your &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;kid&lt;/ins&gt;'s) &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;clinical problems consisting of &lt;/ins&gt;clinical depression, mood &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;troubles&lt;/ins&gt;, self-destructive &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;thoughts &lt;/ins&gt;[https://www.&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;protopage&lt;/ins&gt;.com/&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;buvaelnlz4 Bookmarks&lt;/ins&gt;] or behavior, any type of allergy to SABRIL, vision &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;problems&lt;/ins&gt;, kidney &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;troubles&lt;/ins&gt;, low red &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;blood &lt;/ins&gt;cell &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;counts &lt;/ins&gt;(anemia), and any kind of nervous or psychological ailment.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The Vigabatrin REMS Program is &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;needed &lt;/ins&gt;by the FDA to make &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;sure informed &lt;/ins&gt;risk-benefit decisions prior to &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;starting &lt;/ins&gt;therapy, and to &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;guarantee appropriate &lt;/ins&gt;use vigabatrin while people are treated. When vision loss will &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;certainly happen&lt;/ins&gt;, it is not feasible for your &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;medical care service provider &lt;/ins&gt;to recognize. &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;One of the most usual negative effects of &lt;/ins&gt;SABRIL &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;in kids &lt;/ins&gt;3 &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;to 16 years &lt;/ins&gt;is &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;weight gain&lt;/ins&gt;. &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;With severe vision loss, &lt;/ins&gt;you &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;might only &lt;/ins&gt;have &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;the ability to see things right in front of you (in some cases called one-track mind&quot;). You go to danger for vision loss with &lt;/ins&gt;any type of &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;quantity of SABRIL&lt;/ins&gt;.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Tell your &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;doctor &lt;/ins&gt;if you are expectant or &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;intend &lt;/ins&gt;to obtain expectant. If vision screening can not be done, your doctor may continue &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;recommending &lt;/ins&gt;SABRIL, &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;however &lt;/ins&gt;will certainly not be able to &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;watch &lt;/ins&gt;for any type of vision loss. &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Your medical care carrier &lt;/ins&gt;might quit &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;prescribing &lt;/ins&gt;SABRIL for you (or your youngster)&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;if vision tests are not done routinely&lt;/ins&gt;.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>AmelieKeble0591</name></author>
	</entry>
	<entry>
		<id>http://emdrive.echothis.com/index.php?title=Uses_Side_Consequences_Communications_Photo_Warnings_Application.&amp;diff=85100&amp;oldid=prev</id>
		<title>CyrusBasaldua3: Created page with &quot;Before starting SABRIL, inform your doctor regarding all of your (or your child's) medical conditions including clinical depression, mood problems, self-destructive ideas [https://www.symbaloo.com/embed/shared/AAAABVLIzQ8AA41_0kZ5qw== vigabatrin trade name] or behavior, any type of allergy to SABRIL, vision issues, kidney issues, low red cell matters (anemia), and any kind of nervous or psychological ailment.&lt;br&gt;&lt;br&gt;The Vigabatrin REMS Program is required by the FDA to m...&quot;</title>
		<link rel="alternate" type="text/html" href="http://emdrive.echothis.com/index.php?title=Uses_Side_Consequences_Communications_Photo_Warnings_Application.&amp;diff=85100&amp;oldid=prev"/>
		<updated>2024-06-27T18:19:02Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;Before starting SABRIL, inform your doctor regarding all of your (or your child&amp;#039;s) medical conditions including clinical depression, mood problems, self-destructive ideas [https://www.symbaloo.com/embed/shared/AAAABVLIzQ8AA41_0kZ5qw== vigabatrin trade name] or behavior, any type of allergy to SABRIL, vision issues, kidney issues, low red cell matters (anemia), and any kind of nervous or psychological ailment.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The Vigabatrin REMS Program is required by the FDA to m...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Before starting SABRIL, inform your doctor regarding all of your (or your child's) medical conditions including clinical depression, mood problems, self-destructive ideas [https://www.symbaloo.com/embed/shared/AAAABVLIzQ8AA41_0kZ5qw== vigabatrin trade name] or behavior, any type of allergy to SABRIL, vision issues, kidney issues, low red cell matters (anemia), and any kind of nervous or psychological ailment.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The Vigabatrin REMS Program is required by the FDA to make certain educated risk-benefit decisions prior to launching therapy, and to make sure proper use of vigabatrin while people are treated. When vision loss will take place, it is not feasible for your healthcare supplier to recognize. &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;It is recommended that your healthcare provider examination your (or your kid's) vision prior to or within 4 weeks after beginning SABRIL and a minimum of every 3 months throughout treatment until SABRIL is stopped. If you or your kid have any type of side impact that bothers you or that does not go away, inform your healthcare service provider.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Tell your healthcare provider if you are expectant or mean to obtain expectant. If vision screening can not be done, your doctor may continue suggesting SABRIL, yet will certainly not be able to look for any type of vision loss. If vision tests are not done frequently, your doctor might quit suggesting SABRIL for you (or your youngster).&lt;/div&gt;</summary>
		<author><name>CyrusBasaldua3</name></author>
	</entry>
</feed>